Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 94,84 € | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | 21,36 € | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,51 € | 3,70 € | 145,03 % |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | 4,57 € | 4,62 € | 1,01 % |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | 9,28 € | 25,20 € | 171,64 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 18,58 € | 26,01 € | 40,01 % |
| Xencor Inc. | 10 | 1 | 1 | 0 | 21,60 € | 32,58 € | 50,83 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 31,40 € | 38,99 € | 24,17 % |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | 33,80 € | 41,81 € | 23,71 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 40,40 € | 47,17 € | 16,76 % |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | 22,94 € | 52,03 € | 126,79 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 50,37 € | 55,00 € | 9,19 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | 37,40 € | 84,74 € | 126,59 % |
| Neurocrine Bioscience | 29 | 0 | 6 | 0 | 128,60 € | 140,60 € | 9,33 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 145,90 € | 184,76 € | 26,63 % |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | 200,40 € | 248,57 € | 24,04 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 253,30 € | 287,40 € | 13,46 % |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | 360,30 € | 421,61 € | 17,01 % |